Prosight Management, LP - ALBIREO PHARMA INC ownership

ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 112 filers reported holding ALBIREO PHARMA INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.2%.

Quarter-by-quarter ownership
Prosight Management, LP ownership history of ALBIREO PHARMA INC
ValueSharesWeighting
Q4 2022$10,518,149
+10.6%
486,726
-0.9%
5.74%
+12.6%
Q3 2022$9,510,000
+2.4%
491,244
+5.0%
5.10%
-30.4%
Q2 2022$9,290,000
-35.1%
467,795
-2.5%
7.32%
-20.8%
Q1 2022$14,318,000
+19.6%
480,000
-6.6%
9.25%
+29.0%
Q4 2021$11,973,000
-13.8%
514,082
+15.5%
7.17%
-6.2%
Q3 2021$13,885,000
+33.8%
445,020
+50.8%
7.64%
+17.7%
Q2 2021$10,381,000
+72.9%
295,080
+73.2%
6.49%
+32.0%
Q1 2021$6,005,000
-8.4%
170,352
-2.5%
4.92%
+62.3%
Q4 2020$6,556,000
+60.4%
174,791
+42.7%
3.03%
+55.8%
Q3 2020$4,088,000
-22.4%
122,500
-38.4%
1.94%
-14.0%
Q2 2020$5,266,000
-2.6%
198,800
-39.8%
2.26%
-10.6%
Q1 2020$5,409,000
-13.9%
330,407
+33.7%
2.53%
-8.4%
Q4 2019$6,283,000
+24.4%
247,178
-2.1%
2.76%
-1.5%
Q3 2019$5,050,000
-38.2%
252,500
-0.3%
2.80%
-32.0%
Q2 2019$8,167,000
-6.0%
253,327
-6.1%
4.12%
+8.3%
Q1 2019$8,691,000
+31.1%
269,836
-0.1%
3.80%
+11.2%
Q4 2018$6,627,000
+23.4%
270,146
+65.8%
3.42%
+14.3%
Q3 2018$5,369,000162,9052.99%
Other shareholders
ALBIREO PHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 1,704,330$60,504,0001.59%
Birchview Capital, LP 38,000$1,349,0000.92%
Virtus ETF Advisers LLC 24,688$876,0000.77%
BVF INC/IL 220,000$7,810,0000.76%
SECTORAL ASSET MANAGEMENT INC 172,803$6,135,0000.69%
Chicago Capital, LLC 134,748$4,784,0000.39%
Artal Group S.A. 500,000$17,750,0000.38%
TPG Group Holdings (SBS) Advisors, Inc. 716,381$25,432,0000.33%
Eversept Partners, LP 18,029$640,0300.29%
HEARTLAND ADVISORS INC 125,000$4,438,0000.29%
View complete list of ALBIREO PHARMA INC shareholders